Pirfenidone Promising for RA - Linked Interstitial Lung Disease

Phase 2 trial terminated early, underpowered to meet primary end point, but limited results suggest pirfenidone may slow progression of RA - ILD
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news